Long‐term recurrence (maximal · patients with oesophageal cancer
Non‐surgical showed no clear difference in long‐term recurrence (time‐to‐event outcome) Local recurrence,… compared with surgical treatment of oesophageal cancer (secondary outcomes) (low certainty).
1 finding from 1 review
Long‐term mortality (binary outcome) All‐cause mortality for the duration of · patients with oesophageal cancer
Non‐surgical showed no clear difference in long‐term mortality (binary outcome) All‐cause mortality for the… compared with surgical treatment of oesophageal cancer (primary outcomes) (low certainty).
2 findings from 1 review
Long‐term mortality (time‐to‐event outcome): chemoradiotherapy versus surgery All‐cause mortality for the duration of · patients with oesophageal cancer
Non‐surgical showed no clear difference in long‐term mortality (time‐to‐event outcome): chemoradiotherapy… compared with surgical treatment of oesophageal cancer (primary outcomes) (low certainty).
2 findings from 1 review
Long‐term mortality (time‐to‐event outcome): radiotherapy versus surgery All‐cause mortality for the duration of · patients with oesophageal cancer
It is very uncertain whether non‐surgical changes long‐term mortality (time‐to‐event outcome): radiotherapy versus… compared with surgical treatment of oesophageal cancer (primary outcomes) (very low certainty).
1 finding from 1 review
Long‐term mortality · people requiring surgery for chronic pancreatitis
It is very uncertain whether duodenum‐preserving pancreatic resection changes long‐term mortality compared with pancreaticoduodenectomy (very low certainty).
1 finding from 1 review
Relief of pain · participants with painful obstructive chronic pancreatitis
Endoscopy probably leads to higher pain relief ‐ long‐term compared with surgery (moderate certainty).
1 finding from 1 review
Quality of Life: SF‐36 (physical component) · participants with painful obstructive chronic pancreatitis
1 finding from 1 review
Health‐related quality of life (mental) · participants with painful obstructive chronic pancreatitis
1 finding from 1 review
Endocrine pancreatic insufficiency (new onset) ‐ long‐term · participants with painful obstructive chronic pancreatitis
Endoscopy showed no clear difference in endocrine pancreatic insufficiency (new onset) ‐ long‐term compared with surgery (low certainty).
1 finding from 1 review
Exocrine pancreatic insufficiency (new onset) · participants with painful obstructive chronic pancreatitis
Endoscopy showed no clear difference in exocrine pancreatic insufficiency (new onset) ‐ long‐term compared with surgery (moderate certainty).
1 finding from 1 review
Number of participants with worsening scores in corporal atrophy · people with pre‐malignant lesions
Proton pump inhibitor showed no clear difference in number of participants with worsening scores in corporal atrophy compared with control (low certainty).
1 finding from 1 review
Number of participants with worsening scores in corporal intestinal metaplasia · people with pre‐malignant lesions
Proton pump inhibitor showed no clear difference in number of participants with worsening scores in corporal intestinal… compared with control (low certainty).
1 finding from 1 review
Increase in the number of participants with simple (diffuse) hyperplasia after treatment · people with pre‐malignant lesions
It is very uncertain whether proton pump inhibitor changes increase in the number of participants with simple (diffuse)… compared with control (very low certainty).
1 finding from 1 review
Increase in the number of participants with linear/micronodular (focal) hyperplasia, comparing final biopsies with baseline biopsies · people with pre‐malignant lesions
Proton pump inhibitor may leads to higher increase in the number of participants with linear/micronodular… compared with control (low certainty).
1 finding from 1 review